Great Novel Therapeutics Biotech & Medicals Balance Sheet Health
Financial Health criteria checks 6/6
Great Novel Therapeutics Biotech & Medicals has a total shareholder equity of NT$618.0M and total debt of NT$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are NT$644.8M and NT$26.8M respectively.
Key information
0%
Debt to equity ratio
NT$0
Debt
Interest coverage ratio | n/a |
Cash | NT$476.55m |
Equity | NT$618.04m |
Total liabilities | NT$26.81m |
Total assets | NT$644.85m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7427's short term assets (NT$485.5M) exceed its short term liabilities (NT$15.9M).
Long Term Liabilities: 7427's short term assets (NT$485.5M) exceed its long term liabilities (NT$10.9M).
Debt to Equity History and Analysis
Debt Level: 7427 is debt free.
Reducing Debt: 7427 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 7427 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 7427 has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 16.9% each year